Patent details

Basic Information

Publication number:

EP2635297

PCT Application Number:

US2011059297

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP118388636

PCT Publication Number:

WO2012061689

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

A NEW VARIANT OF ANTIHEMOPHILIC FACTOR VIII HAVING INCREASED SPECIFIC ACTIVITY

French Title of Invention:

UN NOUVEAU VARIANT DU FACTEUR VIII ANTI-HÉMOPHILE AYANT UNE ACTIVITÉ SPÉCIFIQUE ACCRUE

German Title of Invention:

NEUE VARIANTE DES ANTIHÄMOPHILEN FAKTORS VIII MIT ERHÖHTER SPEZIFISCHER AKTIVITÄT

SPC Number:

Dates

Filing date:

04/11/2011

Grant date:

27/02/2019

EP Publication Date:

11/09/2013

PCT Publication Date:

10/05/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/02/2019

EP B1 Publication Date:

27/02/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/11/2019

Expiration date:

04/11/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/02/2019

 

 

Name:

Baxalta GmbH

Address:

Zaehlerweg 4, 6300 Zug, Switzerland (CH)

Name:

Baxalta Incorporated

Address:

1200 Lakeside Drive, Bannockburn, IL 60015, United States (US)

Inventor

1

Name:

STAFFORD, Roddy, Kevin

Address:

United States (US)

2

Name:

LAI, Chee Kong

Address:

United States (US)

Priority

Priority Number:

410437 P

Priority Date:

05/11/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/37; A61K 35/14;

Publication

European Patent Bulletin

Issue number:

201909

Publication date:

27/02/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages